HeartFlow hopes to gather real-world data from up to 10,000 patients with suspected CAD.

Members of Congress are now asking the FDA to investigate a parent's claim that her 14-year-old son was treated with an experimental heart valve without proper consent. The valve eventually failed and had to be replaced. The hospital has said its heart team did nothing wrong. 

Performing virtual reality simulations before TAVR may help cardiologists anticipate when PVL could be an issue in patients with severe BAV AS.

Peripheral artery disease (PAD) leads to more than 400 leg amputations per day in the U.S. Kumar Madassery, MD, discussed the importance of increasing awareness and reaching patients before it is too late. 

The portable device uses HeartBeam's patented 3D vectorelectrocardiography (3D VECG) technology to capture signals from three different projections and deliver a synthetic 12-lead ECG.

Just 10.5% of U.S. physicians said they view private equity ownership in healthcare in a positive light. 

The shields can significantly reduce radiation exposure, according to cardiologist David G. Rizik, MD. He said they also allow cardiologists, nurses and other cath lab employees to provide care without wearing lead aprons. 

The FDA-approved technology developed by HeartFlow can predict a patient's long-term risk of target vessel failure as well as more invasive treatments performed inside a cath lab.